Not enough evidence to justify ovarian cancer screening

Screening women for ovarian cancer should not be considered until the potential benefit, harm, and cost have been assessed in randomised clinical trials, says a report from the NHS Centre for Reviews and Dissemination.

Dr Ruth Bell, a visiting research fellow at the centre, and her coauthors said that a systematic review of prospective screening studies showed that ultrasound screening and the serum test for CA125 could detect ovarian cancer …